Earnings Feed
Sign Up
Home/Insiders/HAYWARD SURRY JEREMY
HS
SEC Insider//CIK 0001245362

HAYWARD SURRY JEREMY

CIK 00012453623 companiesWATERTOWN, MA
SEC Profile

Transactions

50

Companies

3

Filings

7

CIK

0001245362

Recent Transactions

50 trades
  • Award
    PANACOS PHARMACEUTICALS, INC.

    Stock option (right to buy)

    2006-07-27+10,000→ 10,000 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common Stock, $.01 par value per share

    2005-09-30$3.77/sh+2,122→ 21,046 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common Stock, $.01 par value per share

    2005-09-30$3.77/sh+2,122→ 21,046 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Option to Purchase Common Stock , $.01 par value

    2005-09-30+10,000→ 10,000 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Option to Purchase Common Stock , $.01 par value

    2005-09-30+10,000→ 10,000 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common Stock, $.01 par value per share

    2005-06-30$4.41/sh+1,814→ 18,924 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Option to Purchase Common Stock, $.01 par value

    2005-06-30$4.41/sh+10,000→ 10,000 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common Stock, $.01 par value per share

    2005-06-30$4.41/sh+1,814→ 18,924 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Option to Purchase Common Stock, $.01 par value

    2005-06-30$4.41/sh+10,000→ 10,000 total
  • Purchase
    PANACOS PHARMACEUTICALS, INC.

    Common stock

    2005-06-07$3.28/sh+7,500→ 7,500 total
  • Purchase
    PANACOS PHARMACEUTICALS, INC.

    Common stock

    2005-06-07$3.28/sh+7,500→ 7,500 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common stock, $.01 par value per share

    2004-12-31$2.71/sh+2,310→ 6,637 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Options to purchase common stock, $.01 par value per share

    2004-12-31$2.71/sh+10,000→ 40,833 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common stock, $.01 par value per share

    2004-12-31$2.71/sh+2,310→ 6,637 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Options to purchase common stock, $.01 par value per share

    2004-12-31$2.71/sh+10,000→ 40,833 total
  • Award
    PANACOS PHARMACEUTICALS, INC.

    Stock Option (Right to Buy)

    2004-12-27+2,000→ 2,000 total
  • Award
    PANACOS PHARMACEUTICALS, INC.

    Stock Option (Right to Buy)

    2004-12-27+2,000→ 2,000 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Options to purchase common stock, $.01 par value per share

    2003-12-31$4.61/sh+5,000→ 10,833 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common stock, $.01 par value per share

    2003-12-31$4.61/sh+542→ 1,037 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Options to purchase common stock, $.01 par value per share

    2003-12-31$4.61/sh+5,000→ 10,833 total
  • Award
    SAVIENT PHARMACEUTICALS INC

    Common stock, $.01 par value per share

    2003-12-31$4.61/sh+542→ 1,037 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.46/sh−1,000→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.47/sh−300→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.48/sh−1,700→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.50/sh−2,700→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+4,800→ 43,484 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.53/sh−16,100→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Employee Stock Option (Right to Buy)

    2003-10-10−18,750→ 0 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,700→ 40,384 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+16,100→ 54,784 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.55/sh−500→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.56/sh−4,800→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,900→ 40,584 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,000→ 39,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+500→ 39,184 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.49/sh−1,000→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+300→ 38,984 total
  • Exercise/Conversion
    PALL CORP

    Employee Stock Option (Right to Buy)

    2003-10-10−11,250→ 7,500 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,000→ 39,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.57/sh−1,900→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+2,700→ 41,384 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,000→ 39,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.46/sh−1,000→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.50/sh−2,700→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.47/sh−300→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.57/sh−1,900→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Common Stock

    2003-10-10$18.44/sh+1,000→ 39,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.48/sh−1,700→ 38,684 total
  • Sale
    PALL CORP

    Common Stock

    2003-10-10$23.49/sh−1,000→ 38,684 total
  • Exercise/Conversion
    PALL CORP

    Employee Stock Option (Right to Buy)

    2003-10-10−11,250→ 7,500 total

Companies

3

Recent Filings

7

Address

C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE

WATERTOWN, MA, 02472

View on SEC.gov